ask="3.60"
ask_size="1000"
average_daily_volume="186815"
bid="2.95"
bid_size="500"
book_value="3.71"
change="-0.03"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-4.39"
change_From_52_week_low="1.15"
change_in_percent="-0.99%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-10.88"
ebitda="-7.84M"
eps_estimate_current_year="-1.18"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.27"
ex_dividend_date="N/A"
float_shares="954000"
high="3.05"
high_52_weeks="7.39"
last_trade_date="2/6/2017"
last_trade_price="3.00"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.99"
low_52_weeks="1.85"
market_capitalization="29.37M"
moving_average_200_day="3.47"
moving_average_50_day="3.01"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.00"
open="3.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.44%"
percent_change_from_50_day_moving_average="-0.48%"
percent_change_from_52_week_high="-59.40%"
percent_change_from_52_week_low="+62.16%"
previous_close="3.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.82"
price_per_sales="2.30"
revenue="12.87M"
shares_outstanding="9790000"
short_ratio="1.11"
stock_exchange="NCM"
symbol="KOOL"
volume="11136"
weeks_range_52="1.85 - 7.39"
